Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

By Cibula D.  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 143-150

Adis International

Access to resources Recommend Favorite

Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg: A Pooled Analysis

By Anttila Leena  

Clinical Drug Investigation, Vol. 31, Iss. 8, 2011-08 ,pp. : 519-525

Adis International

Access to resources Recommend Favorite

Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg: As an Oral Contraceptive

By Wagstaff Antona J.  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2473-2477

Adis International

Access to resources Recommend Favorite

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

By Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Safety Data and Beneficial Effects of the Combined Oral Contraceptive Ethinylestradiol 0.03 mg/Chlormadinone Acetate 2 mg (Belara®): A 13-Cycle, Observational Study in Routine Clinical Practice

By Pushparajah Daphnee S.  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 121-134

Adis International

Access to resources Recommend Favorite